High consumption of sugary drinks ups risk of cardiometabolic disease: Study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-08-08 12:00 GMT   |   Update On 2022-08-08 12:06 GMT
Advertisement

USA: People who consume high amount of sugar-sweetened beverages (sodas and fruit drinks) may be at higher cardiometabolic risk, says a recent study published in The Journal of Nutrition.

The study stated that higher consumption of sugar-sweetened beverages (SSB) was associated with emerging features of dyslipidemia that have been tied to higher cardiometabolic risk.

Prospective cohort studies have reported a relation between the consumption of sugar-sweetened beverage and dyslipidemia. There is not much evidence linking the consumption of SSB to emerging dyslipidemia features, which can be characterized by variation in lipoprotein particle size, remnant-like particle (RLP), and apolipoprotein concentrations.

Advertisement

Against the above background, Danielle E Haslam, Brigham and Women's Hospital, Boston, Massachusetts, USA, and colleagues aimed to investigate  the association between SSB consumption and plasma lipoprotein cholesterol, apolipoprotein, and lipoprotein particle size concentrations among US adults.

For this purpose, the researchers examined participants from the Framingham Offspring Study (FOS) (1987-1995; n = 3047) and the Women's Health Study (1992; n = 26,218). They quantified plasma LDL-C, apolipoprotein (apo) B, HDL-C, apoA1, triglyceride (TG), non-HDL-C, total: HDL-cholesterol ratio, and apoB: apoA1 concentrations in both the cohorts. apoE, apoC3, RLP-TG, and RLP-cholesterol concentrations were quantified in FOS only. 

Calculation of lipoprotein sizes was done from NMR signals for lipoprotein particle subclass concentrations (triglyceride-rich lipoprotein particles [TRL-P; very large, large, medium, small, and very small], HDL-particles [HDL-P; large, medium, and small]), and LDL-particles [LDL-P; large, medium, and small]. Food frequency questionnaire data estimated SSB consumption. 

The study led to the following findings:

  • SSB consumption was positively associated with LDL-C, apoB, TG, RLP-TG, RLP-C, non-HDL-C concentrations and total: HDL cholesterol and apoB: apoA1 ratio, and negatively associated with HDL-C and apoA1 concentrations.
  • After adjustment for traditional lipoprotein risk factors, SSB consumers had smaller LDL-P and HDL-P sizes, lower concentrations of large LDL-P and medium HDL-P, and higher concentrations of small LDL-P, small HDL-P, and large TRL-P.

The researchers conclude, "higher SSB consumption was associated with multiple emerging features of dyslipidemia that have been linked to higher cardiometabolic risk in US adults."

Reference:

Danielle E Haslam, Daniel I Chasman, Gina M Peloso, Mark A Herman, Josée Dupuis, Alice H Lichtenstein, Caren E Smith, Paul M Ridker, Paul F Jacques, Samia Mora, Nicola M McKeown, Sugar-sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in U.S. Adults, The Journal of Nutrition, 2022;, nxac166, https://doi.org/10.1093/jn/nxac166

Tags:    
Article Source : The Journal of Nutrition

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News